Literature DB >> 6136971

Acquired alpha-thalassemia in preleukemia is due to decreased expression of all four alpha-globin genes.

N P Anagnou, T J Ley, B Chesbro, G Wright, C Kitchens, S Liebhaber, A W Nienhuis, A B Deisseroth.   

Abstract

A somatic mutation(s), acquired during the evolution of preleukemia in a 75-year-old Caucasian male of North European origin, resulted in a marked decrease in alpha-globin mRNA. The small amount of alpha-globin mRNA present in bone marrow cells was normally processed, had a normal (alpha 1/alpha 2)-globin mRNA ratio, and was translated normally. No detectable zeta-globin mRNA was found. The alpha- and zeta-globin genes were both hypomethylated and restriction endonuclease maps of the alpha- and zeta-globin genes were comparable in the patient's marrow and fibroblast DNA. The data are most consistent with the acquisition of a mutation(s) that resulted in decreased expression of all four alpha-globin genes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136971      PMCID: PMC534358          DOI: 10.1073/pnas.80.19.6051

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  An unstable haemoglobin associated with some cases of leukaemia.

Authors:  J C WHITE; M ELLIS; P N COLEMAN; G H BEAVEN; W B GRATZER; E M SHOOTER; E R SKINNER
Journal:  Br J Haematol       Date:  1960-04       Impact factor: 6.998

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Acquired haemoglobin H disease in leukemia: pathophysiology and molecular basis.

Authors:  D J Weatherall; J Old; J Longley; W G Wood; J B Clegg; A Pollock; M J Lewis
Journal:  Br J Haematol       Date:  1978-03       Impact factor: 6.998

5.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes.

Authors:  J C Alwine; D J Kemp; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  [Biochemical study of a case of erythroleukemia. Demonstration in an abnormal erythrocyte population of simultaneous anomalies of hemoglobin and glycolysis enzymes].

Authors:  J Pagnier; D Labie; J C Kaplan; C Junien; A Najman; J P Leroux
Journal:  Nouv Rev Fr Hematol       Date:  1972 May-Jun

7.  Hemoglobin H as an acquired defect of alpha-chain synthesis. Report of two cases.

Authors:  A I Rosenzweig; J D Heywood; A G Motulsky; C A Finch
Journal:  Acta Haematol       Date:  1968       Impact factor: 2.195

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Hemoglobin messenger RNA from human bone marrow. Isolation and translation in homozygous and heterozygous beta-thalassemia.

Authors:  A W Nienhuis; P H Canfield; W F Anderson
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

10.  Acquired hemoglobin H in refractor sideroblastic anemia. A preleukemic marker.

Authors:  W M Boehme; T A Piira; J E Kurnick; N C Bethlenfalvay
Journal:  Arch Intern Med       Date:  1978-04
View more
  2 in total

1.  S1 nuclease analysis of alpha-globin gene expression in preleukemic patients with acquired hemoglobin H disease after transfer to mouse erythroleukemia cells.

Authors:  J Helder; A Deisseroth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

2.  Clonal hematopoiesis and acquired thalassemia in common variable immunodeficiency.

Authors:  M Belickova; H W Schroeder; Y L Guan; J Brierre; S Berney; M D Cooper; J T Prchal
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.